|Teva Continues to Advance Care for Society’s Health and Wellbeing; 2016 Social Impact Report Released|
In 2016, Teva engaged more than 300,000 people in 35 countries in programs aimed to help and empower patients as they deal with their illnesses.
These patient support programs are among the outcomes of broader efforts aimed to better understand and support patient needs and are covered in Teva's 2016 Social Impact Report. Recently released, the report provides an overview of the company's progress toward delivering affordable medicines to patients around world and reflects the company's continued efforts to integrate Corporate Social Responsibility into its business practices.
Among other efforts to fulfill its ambition as a socially and environmentally responsible company, Teva contributed $48.4 million in 28 countries to support patients and communities, responded rapidly to drug shortages in several countries and provided rare medicines to enable organ transplants and prevent the spread of multidrug-resistant tuberculosis in countries who could otherwise not afford such drugs. Teva also continued to encourage diverse talent by maintaining a gender-equal global network of employees, with women representing 47% of the global workforce and 49% of managers.
Additional Highlights of Teva's efforts in 2016 include:
With the world's largest medicine cabinet with a unique specialty portfolio, Teva is committed to making treatments more accessible and affordable for patients, caregivers and healthcare professionals, while addressing future health needs in a responsible, sustainable way.